United States Coronavirus Testing Kits Market to Grow with Increasing Threat until 2026
Worsening conditions of the on-going pandemic is driving the growth of United States coronavirus testing kits market in the forecast period.
According to TechSci report on, “United States Coronavirus Testing Kits Market By Type of Test (Molecular v/s Serological), By Use (Multiple Test v/s Single Test), By Full Test Time (5 Hours-12Hours, 1 Hours- 5 Hours,15-60Minutes, Less than 15 Minutes,12 Hours-24Hours, More Than 1 Day), By Technology (RT-PCR v/s Rapid Diagnostic Test), By Specimen Type (Nasopharyngeal Specimen, Oropharyngeal Specimen, Blood, Sputum, Others), By Mobility (Stationary v/s Mobile), By End User (Public Health Labs, Hospitals, Private or Commercial Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026”,United States coronavirus testing kits market is projected to show a robust growth in the upcoming five years with an impressive CAGR. The market attributes responsible for the growth in the forecast years, 2022-2026 include the recent outbreak as well as the uncontrollable spread of COVID-19 virus which is a strain of coronavirus that has been deemed as a pandemic by World Health Organization since March 2020. Moreover, the surge in the demand of the coronavirus testing kits is also due to the increased demand and requirement of early diagnostics of the virus in the upcoming years. The virus has already shown a multiple variant and each variant causes deadly infection that ultimately leads to the untimely demises of the population suffering. Furthermore, the increasing number of protests and population demand of the finishing the lockdown and resuming the normal life has forced the government to act fast and efficiently to identify and diagnose the infected and resume the life in the country out of complete lockdown.
Although, multiple strains outbreak is creating a challenge for the government, the development of the vaccination has allowed the citizens of the country to be free of their facemasks and lockdowns. Coronavirus Testing Kits often contains a sample collection material, testing serum (in case of molecular tests), and protective gears for the technicians. The ongoing novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease has an efficiency of spreading into a pandemic. It was first discovered in December 2019 in the Wuhan City, China and by March 2020 it was declared to be a pandemic due its wide spread by the World Health Organization, WHO.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on “United States Coronavirus Testing Kits Market”
https://www.techsciresearch.com/report/united-states-coronavirus-testing-kits-market/7505.html
The United States coronavirus testing kits market is segmented by type of test, use, full test time, technology, specimen type, mobility, end user, competitional landscape and regional distribution. Based on technology, the market is further bifurcated into RT-PCR v/s rapid diagnostic test. Rapid diagnostic test is a medical diagnostic test that are performed in case the diagnosis requires faster and efficient ways of any infectious diseases. For the diagnosis of coronavirus, the rapid antigen test is carried out which is a type of rapid diagnostic test. This test detects the presence of the antigen responsible for causing the infection. For the identification of the SARS-CoV-2, the proteins that the virus produces is separated out and compared with the protein samples present in the questionable sample. If the presence of protein can be confirmed, the patient is confirmed to be infected with the COVID-19 virus.
RT-PCR is reverse transcriptase polymerase chain reaction method of the infection diagnosis. In this process, the blood sample, or nasal sample or oral sample of the sputum is collected. The cells present in the samples are then broken and genetic material inside the cells are extracted. This process extracts human as well as the viral genetic material. Presence of reverse transcriptase enzyme ensures that for the test, only viral genetic material is separated out. This is then tested by amplifying the viral genetic material and diagnosing its functions. RT-PCR for coronavirus diagnosis stands for Real-Time Reverse Transcriptase Polymerase Chain Reaction.
Holding the largest market revenue shares are a partial list of market players that includes Roche Diagnostics Corporation, Abbott Laboratories, Inc., Becton, Dickinson, and Company, Siemens Medical Solutions USA, Inc., Thermo Fischer Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Ltd., Ortho-Clinical Diagnostics, Inc., PerkinElmer Inc., Qiagen Inc., among others. The market players have rapidly increased the production and distribution to satisfy the consumer demand. Moreover, research and development of the advanced kits that may provide faster and easier ways to test for the infectious disease and help categorize the infection level is being progressed. Other strategic recommendation includes partnerships between the market players and the research labs dedicated for the development.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7505
Customers can also request for 10% free customization on this report.
“Coronavirus test kit demand are experiencing surge in the country owing to the rapid increase in the patient count and the threat. Although the recent development in the vaccination process and the express delivery of the vaccines has resulted in slight slowing demand of testing kits. Although the country has been exporting the manufactured testing kits to the countries in Asia Pacific region and still has expectant growth in the forecast years,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Coronavirus Testing Kits Market By Type of Test (Molecular v/s Serological), By Use (Multiple Test v/s Single Test), By Full Test Time (5 Hours-12 Hours, 1 Hours- 5 Hours,15-60 Minutes, Less than 15 Minutes,12 Hours-24Hours, More Than 1 Day), By Technology (RT-PCR v/s Rapid Diagnostic Test), By Specimen Type (Nasopharyngeal Specimen, Oropharyngeal Specimen, Blood, Sputum, Others), By Mobility (Stationary v/s Mobile), By End User (Public Health Labs, Hospitals, Private or Commercial Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026” has evaluated the future growth potential of United States Coronavirus Testing Kits market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the United States coronavirus testing kits market.
Browse Related Projects:
Global Coronavirus Testing Kits Market By Type of Test (Molecular v/s Serological), By Use (Multiple Test v/s Single Test), By Full Test Time (5 Hours-12Hours, 1 Hours-5 Hours, 15-60 Minutes, Less than 15 Minutes, 12 Hours-24Hours, More Than 1 Day), By Technology (RT-PCR, Rapid Diagnostic Test, ELISA Tests, Others), By Specimen Type (Nasopharyngeal specimen, Oropharyngeal specimen, Blood, Sputum, Others), By Mobility (Stationary v/s Mobile), By End Use (Public Health Labs, Hospitals, Private or Commercial Labs, Physician Labs, Others), By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/coronavirus-testing-kits-market/4693.html
United States Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological v/s. Synthetic), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic Application (Cardiovascular Disease, Anti-diabetic, Oncology, Neurological Disorders, Musculoskeletal, Others), By Form (Tablet, Capsule, Injection, Others), By Molecule Type (Small v/s Large), By Potency (High v/s Low), By Drug Type (Innovator v/s Generic), By Region, Competition Forecast & Opportunities, 2016 – 2026
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/
